Susceptibility of rat-derived cells to replication by human immunodeficiency virus type 1.
about
TRIM5α and Species Tropism of HIV/SIVLower levels of gamma interferon expressed by a pseudotyped single-cycle simian immunodeficiency virus enhance immunogenicity in rats.SAMHD1 restricts HIV-1 infection in resting CD4(+) T cells.A mouse model for study of systemic HIV-1 infection, antiviral immune responses, and neuroinvasiveness.Tat and trans-activation-responsive (TAR) RNA-independent induction of HIV-1 long terminal repeat by human and murine cyclin T1 requires Sp1.High natural permissivity of primary rabbit cells for HIV-1, with a virion infectivity defect in macrophages as the final replication barrier.CD4-specific transgenic expression of human cyclin T1 markedly increases human immunodeficiency virus type 1 (HIV-1) production by CD4+ T lymphocytes and myeloid cells in mice transgenic for a provirus encoding a monocyte-tropic HIV-1 isolate.Cardiomyocytes undergo apoptosis in human immunodeficiency virus cardiomyopathy through mitochondrion- and death receptor-controlled pathwaysSAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia.Susceptibility of mink (Mustera vision)-derived cells to replication by human immunodeficiency virus type 1HIV-susceptible transgenic rats allow rapid preclinical testing of antiviral compounds targeting virus entry or reverse transcriptionNuclear import of the preintegration complex is blocked upon infection by human immunodeficiency virus type 1 in mouse cells.Primary T-cells from human CD4/CCR5-transgenic rats support all early steps of HIV-1 replication including integration, but display impaired viral gene expression.Progress toward a human CD4/CCR5 transgenic rat model for de novo infection by human immunodeficiency virus type 1.Aqueous extracts from peppermint, sage and lemon balm leaves display potent anti-HIV-1 activity by increasing the virion density.Intrapulmonary Versus Nasal Transduction of Murine Airways With GP64-pseudotyped Viral VectorsIncreased in vivo activation of microglia and astrocytes in the brains of mice transgenic for an infectious R5 human immunodeficiency virus type 1 provirus and for CD4-specific expression of human cyclin T1 in response to stimulation by lipopolysaccMouse T-cells restrict replication of human immunodeficiency virus at the level of integration.Capsid-dependent and -independent postentry restriction of primate lentivirus tropism in rodent cellsPharmacovirological impact of an integrase inhibitor on human immunodeficiency virus type 1 cDNA species in vivoRelationships between infectious titer, capsid protein levels, and reverse transcriptase activities of diverse human immunodeficiency virus type 1 isolates.Retroviral restriction and dependency factors in primates and carnivores.Role of Nucleocytoplasmic RNA Transport during the Life Cycle of Retroviruses.Impact of raltegravir on HIV-1 RNA and DNA forms following initiation of antiretroviral therapy in treatment-naive patients.HIV-1 susceptibility of transgenic rat-derived primary macrophage/T cells and a T cell line that express human receptors, CyclinT1 and CRM1 genes.SAMHD1's protein expression profile in humans.Expression of Nef downregulates CXCR4, the major coreceptor of human immunodeficiency virus, from the surfaces of target cells and thereby enhances resistance to superinfection.Flow cytometry based identification of simian immunodeficiency virus Env-specific B lymphocytes.β-TrCP is dispensable for Vpu's ability to overcome the CD317/Tetherin-imposed restriction to HIV-1 release.Endogenous CD317/Tetherin limits replication of HIV-1 and murine leukemia virus in rodent cells and is resistant to antagonists from primate viruses.Biological signature characteristics of primary isolates from human immunodeficiency virus type 1 group O in ex vivo human tonsil histocultures.Synergistic effect of human CycT1 and CRM1 on HIV-1 propagation in rat T cells and macrophages.Rodent cells support key functions of the human immunodeficiency virus type 1 pathogenicity factor NefMcCoy cell line as a possible model containing CD4+ receptors for the study of HIV-1 replication.The Nef protein of human immunodeficiency virus is a broad-spectrum modulator of chemokine receptor cell surface levels that acts independently of classical motifs for receptor endocytosis and Galphai signaling.Human cyclin T1 expression ameliorates a T-cell-specific transcriptional limitation for HIV in transgenic rats, but is not sufficient for a spreading infection of prototypic R5 HIV-1 strains ex vivo.EcoHIV infection of mice establishes latent viral reservoirs in T cells and active viral reservoirs in macrophages that are sufficient for induction of neurocognitive impairment.
P2860
Q24304062-99CDCED4-66D2-44A7-82C2-EC2138A3907AQ30373857-35D42D22-D2E4-4B18-9A89-5FDC9C1C1615Q30421200-B02EA8E9-C9F4-4B65-99D8-FFB8A0101157Q33928648-6A06B4E9-3EC8-4274-B5EF-68609FFFC90AQ34161703-781A079F-0F84-41D0-BC8D-A9EBADC21FE2Q34291018-2AE036D0-80CB-4E82-8D34-1E38E16D16C5Q34353412-E8E43B2A-9E7B-41F2-A0D4-77FD30809150Q34393925-81CBC508-B69E-4C8B-A4A9-03935BE364F1Q34547626-2F56DF36-6893-43D9-8B99-08BD03D0E0BFQ34976301-CF6BFF07-910F-430E-B269-6CF754D43210Q35612098-55F4EDAE-E081-4EEF-B1B5-C0164052C66CQ35635000-EBE9A946-77AF-4A65-98E7-CA1876C7A3BAQ35980829-5683B3A9-0084-48F1-A98C-25B84BE3E56FQ36370241-3D97A9BD-0E9D-4E6E-88E6-5F234FEA174AQ36528448-C164F62D-1900-44D0-9468-5590FB1E8EC7Q36587580-E771ECE0-652A-4402-B7DB-632988F8EBBAQ36673268-009EA648-359B-4085-B515-09F9CF00BCEBQ36916993-147BE90C-A29A-4230-BB45-DA08B29B9FD1Q36943400-055EC902-0D1E-4186-A4E4-D376815E9116Q37256641-02476C16-F160-449C-908F-BDFA1C0D1EB2Q37568313-71863229-B89A-41A1-B154-FF4B687D473BQ37895742-B201D316-88F6-4C9F-A78B-722F9096467CQ38025392-EA82A26D-95BA-445E-8944-6580A1778157Q38391209-96104D57-02FA-4DE3-BDE2-C0C5C1903F48Q38711226-DACF8A02-CF2E-44D6-8E93-BAFEA7ADDEE2Q38913628-8D81E2D9-C19C-484F-AAE9-748A1B323D45Q39304735-3DAE0BCA-4956-4D5D-B0CE-A147A134FB9FQ39521335-1D36902F-7CF7-4232-AA22-D62A3361DFB6Q39594626-2B7D499C-03FE-4568-ADBA-FBB28E90F067Q39668496-C772C318-868B-4045-93D0-875E0220FEE2Q39808350-962CCEE3-42B3-4B88-9E57-84ECF9D5A203Q39852737-69A262B4-5DF4-460A-A678-7CE1E609FCF0Q40471343-F77CB58A-CEBE-45F7-A204-6065C7251E11Q40632696-F0DA27A3-4AA3-49DB-9734-AB8F935C0902Q41849313-28E7292E-00B8-4D11-8DE2-EA75B8310B4AQ43193366-76B6ED77-BBE8-4A4C-A76C-2026344F5800Q55255033-AD86AB33-8C1B-4D2A-9AC4-031AFBFF4011
P2860
Susceptibility of rat-derived cells to replication by human immunodeficiency virus type 1.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Susceptibility of rat-derived ...... immunodeficiency virus type 1.
@en
Susceptibility of rat-derived ...... immunodeficiency virus type 1.
@nl
type
label
Susceptibility of rat-derived ...... immunodeficiency virus type 1.
@en
Susceptibility of rat-derived ...... immunodeficiency virus type 1.
@nl
prefLabel
Susceptibility of rat-derived ...... immunodeficiency virus type 1.
@en
Susceptibility of rat-derived ...... immunodeficiency virus type 1.
@nl
P2093
P2860
P1433
P1476
Susceptibility of rat-derived ...... immunodeficiency virus type 1.
@en
P2093
D Iacovides
D L Hirschberg
K S Patton
M A Goldsmith
O T Keppler
R E Atchison
W Yonemoto
P2860
P304
P356
10.1128/JVI.75.17.8063-8073.2001
P407
P577
2001-09-01T00:00:00Z